Literature DB >> 20363365

The utility of general purpose versus specialty clinical databases for research: warfarin dose estimation from extracted clinical variables.

Hersh Sagreiya1, Russ B Altman.   

Abstract

There is debate about the utility of clinical data warehouses for research. Using a clinical warfarin dosing algorithm derived from research-quality data, we evaluated the data quality of both a general-purpose database and a coagulation-specific database. We evaluated the functional utility of these repositories by using data extracted from them to predict warfarin dose. We reasoned that high-quality clinical data would predict doses nearly as accurately as research data, while poor-quality clinical data would predict doses less accurately. We evaluated the Mean Absolute Error (MAE) in predicted weekly dose as a metric of data quality. The MAE was comparable between the clinical gold standard (10.1mg/wk) and the specialty database (10.4 mg/wk), but the MAE for the clinical warehouse was 40% greater (14.1mg/wk). Our results indicate that the research utility of clinical data collected in focused clinical settings is greater than that of data collected during general-purpose clinical care.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363365      PMCID: PMC2928873          DOI: 10.1016/j.jbi.2010.03.014

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  8 in total

1.  The NCBI dbGaP database of genotypes and phenotypes.

Authors:  Matthew D Mailman; Michael Feolo; Yumi Jin; Masato Kimura; Kimberly Tryka; Rinat Bagoutdinov; Luning Hao; Anne Kiang; Justin Paschall; Lon Phan; Natalia Popova; Stephanie Pretel; Lora Ziyabari; Moira Lee; Yu Shao; Zhen Y Wang; Karl Sirotkin; Minghong Ward; Michael Kholodov; Kerry Zbicz; Jeffrey Beck; Michael Kimelman; Sergey Shevelev; Don Preuss; Eugene Yaschenko; Alan Graeff; James Ostell; Stephen T Sherry
Journal:  Nat Genet       Date:  2007-10       Impact factor: 38.330

2.  Medicine. The ultimate model organism.

Authors:  Atul J Butte
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

3.  Stimulus bill implementation: expanding meaningful use of health IT.

Authors:  Rob Cunningham
Journal:  Issue Brief George Wash Univ Natl Health Policy Forum       Date:  2009-08-25

4.  Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

Authors:  Mark J Rieder; Alexander P Reiner; Brian F Gage; Deborah A Nickerson; Charles S Eby; Howard L McLeod; David K Blough; Kenneth E Thummel; David L Veenstra; Allan E Rettie
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

Review 5.  Collaborative genome-wide association studies of diverse diseases: programs of the NHGRI's office of population genomics.

Authors:  Teri A Manolio
Journal:  Pharmacogenomics       Date:  2009-02       Impact factor: 2.533

6.  Warfarin pharmacogenomics: a big step forward for individualized medicine: enlightened dosing of warfarin.

Authors:  Darlene J Elias; Eric J Topol
Journal:  Eur J Hum Genet       Date:  2008-02-27       Impact factor: 4.246

7.  Medication use leading to emergency department visits for adverse drug events in older adults.

Authors:  Daniel S Budnitz; Nadine Shehab; Scott R Kegler; Chesley L Richards
Journal:  Ann Intern Med       Date:  2007-12-04       Impact factor: 25.391

8.  Estimation of the warfarin dose with clinical and pharmacogenetic data.

Authors:  T E Klein; R B Altman; N Eriksson; B F Gage; S E Kimmel; M-T M Lee; N A Limdi; D Page; D M Roden; M J Wagner; M D Caldwell; J A Johnson
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245

  8 in total
  9 in total

1.  Survival Analysis with Electronic Health Record Data: Experiments with Chronic Kidney Disease.

Authors:  Yolanda Hagar; David Albers; Rimma Pivovarov; Herbert Chase; Vanja Dukic; Noémie Elhadad
Journal:  Stat Anal Data Min       Date:  2014-08-19       Impact factor: 1.051

2.  Learning Optimal Individualized Treatment Rules from Electronic Health Record Data.

Authors:  Yuanjia Wang; Peng Wu; Ying Liu; Chunhua Weng; Donglin Zeng
Journal:  IEEE Int Conf Healthc Inform       Date:  2016-12-08

3.  Identifying and mitigating biases in EHR laboratory tests.

Authors:  Rimma Pivovarov; David J Albers; Jorge L Sepulveda; Noémie Elhadad
Journal:  J Biomed Inform       Date:  2014-04-13       Impact factor: 6.317

4.  A methodology for a minimum data set for rare diseases to support national centers of excellence for healthcare and research.

Authors:  Rémy Choquet; Meriem Maaroufi; Albane de Carrara; Claude Messiaen; Emmanuel Luigi; Paul Landais
Journal:  J Am Med Inform Assoc       Date:  2014-07-18       Impact factor: 4.497

5.  Population physiology: leveraging electronic health record data to understand human endocrine dynamics.

Authors:  D J Albers; George Hripcsak; Michael Schmidt
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

6.  Diagnoses and clinical features associated with high risk for unplanned readmission in vascular surgery. A cohort study.

Authors:  Marina Yiasemidou; Andrew I D Mavor; Patrick J Kent
Journal:  Ann Med Surg (Lond)       Date:  2015-04-14

7.  Phenotyping coronavirus disease 2019 during a global health pandemic: Lessons learned from the characterization of an early cohort.

Authors:  Sarah DeLozier; Sarah Bland; Melissa McPheeters; Quinn Wells; Eric Farber-Eger; Cosmin A Bejan; Daniel Fabbri; Trent Rosenbloom; Dan Roden; Kevin B Johnson; Wei-Qi Wei; Josh Peterson; Lisa Bastarache
Journal:  J Biomed Inform       Date:  2021-04-08       Impact factor: 8.000

8.  Next-generation phenotyping of electronic health records.

Authors:  George Hripcsak; David J Albers
Journal:  J Am Med Inform Assoc       Date:  2012-09-06       Impact factor: 4.497

9.  Illustrating Informed Presence Bias in Electronic Health Records Data: How Patient Interactions with a Health System Can Impact Inference.

Authors:  Matthew Phelan; Nrupen A Bhavsar; Benjamin A Goldstein
Journal:  EGEMS (Wash DC)       Date:  2017-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.